Living donor liver transplantation does not increase tumor recurrence of hepatocellular carcinoma compared to deceased donor transplantation

World Journal of Gastroenterology

Volumn 20, Issue 31, 2014, Pages 10953-10959

  Xiao, Guang Qin ^a   Song, Jiu Lin ^a   Shen, Shu ^a   Yang, Jia Yin ^a   Yan, Lu Nan ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Deceased donor; Hepatitis B virus; Hepatocellular carcinoma; Liver transplantation; Living donor

Indexed keywords

ADULT; ARTICLE; CADAVER DONOR; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SIZE; CHEMOEMBOLIZATION; COMPARATIVE EFFECTIVENESS; FEMALE; FOLLOW UP; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RADIOFREQUENCY ABLATION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; ADVERSE EFFECTS; CARCINOMA, HEPATOCELLULAR; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; KAPLAN MEIER METHOD; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROCEDURES; REGISTER; RISK FACTOR; SUPPLY AND DISTRIBUTION; TIME; TREATMENT OUTCOME; TUMOR RECURRENCE; VIROLOGY;

ADULT; CARCINOMA, HEPATOCELLULAR; CHI-SQUARE DISTRIBUTION; FEMALE; HEPATITIS B; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84909643340     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i31.10953     Document Type: Article

References (36)

1. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, Bozzetti F, Montalto F, Ammatuna M, Morabito A, Gennari L. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-699 [PMID: 8594428 DOI: 10.1056/NEJM199603143341104]
2. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-1403 [PMID: 11391528 DOI: 10.1053/jhep.2001.24563]
3. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transpl 2002; 8: 765-774 [PMID: 12200775 DOI: 10.1053/jlts.2002.34892]
4. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am J Transplant 2007; 7: 2587-2596 [PMID: 17868066 DOI: 10.1111/j.1600-6143.2007.01965.x]
5. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Camerini T, Roayaie S, Schwartz ME, Grazi GL, Adam R, Neuhaus P, Salizzoni M, Bruix J, Forner A, De Carlis L, Cillo U, Burroughs AK, Troisi R, Rossi M, Gerunda GE, Lerut J, Belghiti J, Boin I, Gugenheim J, Rochling F, Van Hoek B, Majno P. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35-43 [PMID: 19058754 DOI: 10.1016/S1470-2045(08)70284-5]
6. Dagradi A, Munari PF, Gamba A, Zannini M, Sussi PL, Serio G. [Problems of surgical anatomy and surgical practice studied with a view to transplantation of sections of the liver in humans]. Chir Ital 1966; 18: 639-659 [PMID: 4866458]
7. Smith B. Segmental liver transplantation from a living donor. J Pediatr Surg 1969; 4: 126-132 [PMID: 4976215 DOI: 10.1016/0022-3468(69)90193-6]
8. Strong RW, Lynch SV, Ong TH, Matsunami H, Koido Y, Balderson GA. Successful liver transplantation from a living donor to her son. N Engl J Med 1990; 322: 1505-1507 [PMID: 2336076 DOI: 10.1056/nejm199005243222106]
9. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004; 10: 440-447 [PMID: 15004774 DOI: 10.1002/lt.20097]
10. Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE. Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients. Liver Transpl 2006; 12: 560-565 [PMID: 16555313 DOI: 10.1002/lt.20660]
11. Di Sandro S, Slim AO, Giacomoni A, Lauterio A, Mangoni I, Aseni P, Pirotta V, Aldumour A, Mihaylov P, De Carlis L. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant Proc 2009; 41: 1283-1285 [PMID: 19460539 DOI: 10.1016/j.transproceed.2009.03.022]
12. Gallegos-Orozco JF, Yosephy A, Noble B, Aqel BA, Byrne TJ, Carey EJ, Douglas DD, Mulligan D, Moss A, de Petris G, Williams JW, Rakela J, Vargas HE. Natural history of post-liver transplantation hepatitis C: A review of factors that may influence its course. Liver Transpl 2009; 15: 1872-1881 [PMID: 19938138 DOI: 10.1002/lt.21954]
13. Li C, Wen TF, Yan LN, Li B, Yang JY, Wang WT, Xu MQ, Wei YG. Outcome of hepatocellular carcinoma treated by liver transplantation: comparison of living donor and deceased donor transplantation. Hepatobiliary Pancreat Dis Int 2010; 9: 366-369 [PMID: 20688599]
14. Di Sandro S, Giacomoni A, Slim A, Lauterio A, Mangoni I, Mihaylov P, Pirotta V, Aseni P, De Carlis L. Living donor liver transplantation for hepatocellular carcinoma: the impact of neo-adjuvant treatments on the long term results. Hepatogastroenterology 2012; 59: 505-510 [PMID: 22353516 DOI: 10.5754/hge11225]
15. Liang W, Wu L, Ling X, Schroder PM, Ju W, Wang D, Shang Y, Kong Y, Guo Z, He X. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: a meta-analysis. Liver Transpl 2012; 18: 1226-1236 [PMID: 22685095 DOI: 10.1002/lt.23490]
16. Sandhu L, Sandroussi C, Guba M, Selzner M, Ghanekar A, Cattral MS, McGilvray ID, Levy G, Greig PD, Renner EL, Grant DR. Living donor liver transplantation versus deceased donor liver transplantation for hepatocellular carcinoma: comparable survival and recurrence. Liver Transpl 2012; 18: 315-322 [PMID: 22140013 DOI: 10.1002/lt.22477]
17. Lei J, Yan L, Wang W. Comparison of the outcomes of patients who underwent deceased-donor or living-donor liver transplantation after successful downstaging therapy. Eur J Gastroenterol Hepatol 2013; 25: 1340-1346 [PMID: 23652915 DOI: 10.1097/MEG.0b013e3283622743]
18. Fisher RA, Kulik LM, Freise CE, Lok AS, Shearon TH, Brown RS, Ghobrial RM, Fair JH, Olthoff KM, Kam I, Berg CL. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant 2007; 7: 1601-1608 [PMID: 17511683 DOI: 10.1111/j.1600-6143.2007.01802.x]
19. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br J Surg 2007; 94: 78-86 [PMID: 17016793 DOI: 10.1002/bjs.5528]
20. Kaido T, Uemoto S. Does living donation have advantages over deceased donation in liver transplantation? J Gastroenterol Hepatol 2010; 25: 1598-1603 [PMID: 20880167 DOI: 10.1111/j.1440-1746.2010.06418.x]
21. Bhangui P, Vibert E, Majno P, Salloum C, Andreani P, Zocrato J, Ichai P, Saliba F, Adam R, Castaing D, Azoulay D. Intention-to-treat analysis of liver transplantation for hepatocellular carcinoma: living versus deceased donor transplantation. Hepatology 2011; 53: 1570-1579 [PMID: 21520172 DOI: 10.1002/hep.24231]
22. Kulik LM, Fisher RA, Rodrigo DR, Brown RS, Freise CE, Shaked A, Everhart JE, Everson GT, Hong JC, Hayashi PH, Berg CL, Lok AS. Outcomes of living and deceased donor liver transplant recipients with hepatocellular carcinoma: results of the A2ALL cohort. Am J Transplant 2012; 12: 2997-3007 [PMID: 22994906 DOI: 10.1111/j.1600-6143.2012.04272.x]
23. Park MS, Lee KW, Suh SW, You T, Choi Y, Kim H, Hong G, Yi NJ, Kwon CH, Joh JW, Lee SK, Suh KS. Living-donor liver transplantation associated with higher incidence of hepatocellular carcinoma recurrence than deceased-donor liver transplantation. Transplantation 2014; 97: 71-77 [PMID: 24056623 DOI: 10.1097/TP.0b013e3182a68953]
24. Yan LN, Li B, Zeng Y, Wen TF, Zhao JC, Wang WT, Yang JY, Xu MQ, Ma YK, Chen ZY, Liu JW, Wu H. Modified techniques for adult-to-adult living donor liver transplantation. Hepatobiliary Pancreat Dis Int 2006; 5: 173-179 [PMID: 16698570]
25. Jiang L, Yan LN. Current therapeutic strategies for recurrent hepatitis B virus infection after liver transplantation. World J Gastroenterol 2010; 16: 2468-2475 [PMID: 20503446 DOI: 10.3748/wjg.v16.i20.2468]
26. Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008; 85: 1726-1732 [PMID: 18580463 DOI: 10.1097/TP.0b013e31816b67e4]
27. Li J, Yan LN, Yang J, Chen ZY, Li B, Zeng Y, Wen TF, Zhao JC, Wang WT, Yang JY, Xu MQ, Ma YK. Indicators of prognosis after liver transplantation in Chinese hepatocellular carcinoma patients. World J Gastroenterol 2009; 15: 4170-4176 [PMID: 19725152 DOI: 10.3748/wjg.15.4170]
28. Picardo A, Karpoff HM, Ng B, Lee J, Brennan MF, Fong Y. Partial hepatectomy accelerates local tumor growth: potential roles of local cytokine activation. Surgery 1998; 124: 57-64 [PMID: 9663252]
29. Shi JH, Huitfeldt HS, Suo ZH, Line PD. Growth of hepatocellular carcinoma in the regenerating liver. Liver Transpl 2011; 17: 866-874 [PMID: 21542129 DOI: 10.1002/lt.22325]
30. Yao FY, Bass NM, Nikolai B, Davern TJ, Kerlan R, Wu V, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: analysis of survival according to the intention-to-treat principle and dropout from the waiting list. Liver Transpl 2002; 8: 873-883 [PMID: 12360427 DOI: 10.1053/jlts.2002.34923]
31. Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J Hepatol 2008; 48 Suppl 1: S20-S37 [PMID: 18304676 DOI: 10.1016/j.jhep.2008.01.022]
32. Lai JC, Pichardo EM, Emond JC, Brown RS. Resource utilization of living donor versus deceased donor liver transplantation is similar at an experienced transplant center. Am J Transplant 2009; 9: 586-591 [PMID: 19191773 DOI: 10.1111/j.1600-6143.2008.02511.x]
33. Cheng SJ, Pratt DS, Freeman RB, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001; 72: 861-868 [PMID: 11571451]
34. Fan ST. Live donor liver transplantation in adults. Transplantation 2006; 82: 723-732 [PMID: 17006315 DOI: 10.1097/01.tp.0000235171.17287.f2]
35. Li C, Mi K, Wen Tf, Yan Ln, Li B, Yang Jy, Xu Mq, Wang Wt, Wei Yg. Outcomes of patients with benign liver diseases undergoing living donor versus deceased donor liver transplantation. PLoS One 2011; 6: e27366 [PMID: 22087299 DOI: 10.1371/journal.pone.0027366]
36. Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl 2004; 10: 1263-1268 [PMID: 15376301 DOI: 10.1002/lt.20254]